A nanoconfined loading strategy for highly efficient siRNA delivery and cancer therapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Dendrimers and Hyperbranched Polymers
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (27)
Show source-provided references
1. Gene therapy comes of age10.1126/science.aan4672 ↗
2. The current state and future directions of RNAi-based therapeutics10.1038/s41573-019-0017-4 ↗
3. RNAi therapies: drugging the undruggable10.1126/scitranslmed.3008362 ↗
4. RNA therapeutics on the rise10.1038/d41573-020-00078-0 ↗
5. Advances and hurdles to clinical translation of RNAi therapeutics10.1016/j.addr.2016.07.003 ↗
6. Overcoming cellular barriers for RNA therapeutics10.1038/nbt.3802 ↗
7. an RNAi therapeutic, for hereditary transthyretin amyloidosis10.1056/NEJMoa1716153 ↗
8. Strategies, design, and chemistry in siRNA delivery systems10.1016/j.addr.2019.05.004 ↗
9. Rekindling RNAi Therapy: materials design requirements for in vivo siRNA delivery10.1002/adma.201903637 ↗
10. Recent progress in development of siRNA delivery vehicles for cancer therapy10.1016/j.addr.2016.06.011 ↗
11. An influenza virus-inspired polymer system for the timed release of siRNA10.1038/ncomms2905 ↗
12. Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment10.1073/pnas.1505629112 ↗
13. N-Alkyl-PEI-functionalized iron oxide nanoclusters for efficient siRNA delivery10.1002/smll.201100825 ↗
14. Hypoxia-targeted siRNA delivery10.1002/ange.201308368 ↗
15. Multifunctional dendronized peptide polymer platform for safe and effective siRNA delivery10.1021/ja400986u ↗
16. Dual-responsive polyplexes with enhanced disassembly and endosomal escape for efficient delivery of siRNA10.1016/j.biomaterials.2018.01.042 ↗
17. Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane10.1073/pnas.1200718109 ↗
18. In vivo disassembly of IV administered siRNA matrix nanoparticles at the renal filtration barrier10.1016/j.biomaterials.2012.11.058 ↗
19. Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA10.1038/nmat2444 ↗
20. Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug10.1073/pnas.1303958110 ↗
21. H.J. Li, J.Z. Du, X.J. Du, C.F. Xu, C.Y. Sun, H.X. Wang, Z.T. Cao, X.Z. Yang, Y.H. Zhu, S. Nie, J. Wang, Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy, Proc. Natl. Acad. Sci. USA 113, 2016, 4164–4169.10.1073/pnas.1522080113 ↗
22. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy10.1016/j.jconrel.2011.07.035 ↗
23. Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells10.1073/pnas.1031523100 ↗
24. Targeting polo-like kinase 1 for cancer therapy10.1038/nrc1841 ↗
25. Immune checkpoint blockade: a common denominator approach to cancer therapy10.1016/j.ccell.2015.03.001 ↗
26. A decade of immune-checkpoint inhibitors in cancer therapy10.1038/s41467-020-17670-y ↗
27. Carrier-free nanoassembly of doxorubicin prodrug and siRNA for combinationally inducing immunogenic cell death and reversing immunosuppression10.1016/j.nantod.2020.100924 ↗